Inventor · disambiguated record
Chengjung Lai
Also filed as: LAI CHENGJUNG
16 granted patents·8 pending applications·93 citations·filing 2011–2025
93Inventor score
Top patents by PatentIndex Score
24 records- 0196US8461157B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCAI XIONG·Filed 2011·Granted Jun 11, 2013·27 cites·19 claims
- 0295US8906909B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2013·Granted Dec 9, 2014·17 cites·20 claims
- 0393US10676482B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2019·Granted Jun 9, 2020·3 cites·4 claims
- 0492US8710219B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCAI XIONG·Filed 2012·Granted Apr 29, 2014·14 cites·8 claims
- 0591US10336770B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2017·Granted Jul 2, 2019·7 cites·13 claims
- 0691US2025230169A1Phosphoinositide 3-Kinase Inhibitors with a Zinc Binding MoietyCURIS INC·Filed 2024·Application pending·0 cites
- 0790US9725461B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2014·Granted Aug 8, 2017·11 cites·18 claims
- 0888US11655473B2Compositions and methods for inhibiting mitochondria amidoxime reducing component 1 (MARC1) expressionNOVO NORDISK AS·Filed 2022·Granted May 23, 2023·2 cites·27 claims
- 0988US9657032B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2015·Granted May 23, 2017·5 cites·21 claims
- 1088US9249156B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2014·Granted Feb 2, 2016·6 cites·9 claims
- 1185US2023227467A1Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2023·Application pending·0 cites
- 1283US11597732B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2022·Granted Mar 7, 2023·0 cites·6 claims
- 1380US10543197B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2018·Granted Jan 28, 2020·1 cites·6 claims
- 1479US11654136B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2021·Granted May 23, 2023·0 cites·12 claims
- 1579US2025283091A1Methods and compositions for inhibiting expression of ldhaNOVO NORDISK HEALTHCARE AG·Filed 2025·Application pending·0 cites
- 1677US11261195B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2020·Granted Mar 1, 2022·0 cites·8 claims
- 1775US10894795B2Phosphoinositide 3-kinase inhibitors with a zinc binding moietyCURIS INC·Filed 2020·Granted Jan 19, 2021·0 cites·8 claims
- 1873US11135205B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2020·Granted Oct 5, 2021·0 cites·18 claims
- 1966US2023340490A1Compositions and methods for inhibiting mitochondria amidoxime reducing component 1 (marc1) expressionNOVO NORDISK AS·Filed 2023·Application pending·0 cites
- 2065US10111864B2Phosphoinositide 3-kinase inhibitor with a zinc binding moietyCURIS INC·Filed 2017·Granted Oct 30, 2018·0 cites·9 claims
- 2165US2025327070A1Compositions and methods for inhibiting complement factor bASTRAZENECA IRELAND LTD·Filed 2023·Application pending·0 cites
- 2261US2025002908A1Compositions and methods for inhibiting complement component 3 expressionASTRAZENECA IRELAND LTD·Filed 2022·Application pending·0 cites
- 2359US2023107967A1Compositions and methods for inhibiting alpha-1 antitrypsin expressionDICERNA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2443US2013102595A1Treatment of cancers having k-ras mutationsCURIS INC·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →